Concepedia

Hans Kelgtermans

HK

2

Publications

80

Citations

2

H-Index

2017

Active since

Affiliations

Galapagos (France)(Current)

Galapagos (Belgium)

Hans Kelgtermans is an author at Galapagos (France) specializing in intracellular trafficking, signal transduction, and drug discovery.

Top concepts

Publications per year

2017–2021

2

Publications

2

Discovery of<i>N</i>-(3-Carbamoyl-5,5,7,7-tetramethyl-5,7-dihydro-4<i>H</i>-thieno[2,3-<i>c</i>]pyran-2-yl)-l<i>H</i>-pyrazole-5-carboxamide (GLPG1837), a Novel Potentiator Which Can Open Class III Mutant Cystic Fibrosis Transmembrane Conductance Regulator (CFTR) Channels to a High Extent

Steven E. Van der Plas, Hans Kelgtermans, Tom De Munck et al. · Journal of Medicinal Chemistry · 2017 · 58 citations · Full text

Discovery of GLPG2451, a Novel Once Daily Potentiator for the Treatment of Cystic Fibrosis

Steven E. Van der Plas, Hans Kelgtermans, Oscar Mammoliti et al. · Journal of Medicinal Chemistry · 2021 · 22 citations · Full text

, , +10

Rows per page

1–2 of 2